The incidence of colorectal cancer (CRC) is increasing with colorectal adenomas recognized as key precancerous lesions.
Emerging evidence suggests that Imidazole propionate (ImP), a metabolite of gut microbiota, is elevated in patients, indicating a potential role in tumorigenesis of CRC.
